ETHZ
ETHZ
NASDAQ · Biotechnology

Ethzilla Corp

$2.89
-0.09 (-3.02%)
As of Apr 1, 3:25 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,570.6% upside
Low Target $28.52
Average Target $48.28
High Target $57.13
Current Price $2.89
Current
$2.89
Target
$48.28
$28.52 $48.28 avg $57.13
Scenario Analysis
Bear Case
$28.52
886.9%
Low target
Base Case
$48.28
+1,570.6%
Avg target
Bull Case
$57.13
+1,876.8%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$74.50
-96.1% from high
52-Week Low
$2.80
+3.3% from low
Target vs 52W High
$48.28
-35.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%